These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16510353)

  • 1. Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells.
    Ahmad S; Ahmad A; Schneider KB; White CW
    Int J Toxicol; 2006; 25(1):17-23. PubMed ID: 16510353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of MTT formazan in lipid droplets. An alternative hypothesis about the nature of formazan granules and aggregates.
    Diaz G; Melis M; Musin A; Piludu M; Piras M; Falchi AM
    Eur J Histochem; 2007; 51(3):213-8. PubMed ID: 17921117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
    Liu Y; Schubert D
    J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction assay for evaluating the viability of Escherichia coli cells.
    Wang H; Cheng H; Wang F; Wei D; Wang X
    J Microbiol Methods; 2010 Sep; 82(3):330-3. PubMed ID: 20619304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The noncellular reduction of MTT tetrazolium salt by TiO₂ nanoparticles and its implications for cytotoxicity assays.
    Lupu AR; Popescu T
    Toxicol In Vitro; 2013 Aug; 27(5):1445-50. PubMed ID: 23531555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
    Abe K; Saito H
    Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability.
    Sylvester PW
    Methods Mol Biol; 2011; 716():157-68. PubMed ID: 21318905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
    Liu Y; Peterson DA; Kimura H; Schubert D
    J Neurochem; 1997 Aug; 69(2):581-93. PubMed ID: 9231715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
    van Tonder A; Joubert AM; Cromarty AD
    BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2.
    Wang S; Yu H; Wickliffe JK
    Toxicol In Vitro; 2011 Dec; 25(8):2147-51. PubMed ID: 21798338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells.
    Marks DC; Belov L; Davey MW; Davey RA; Kidman AD
    Leuk Res; 1992 Dec; 16(12):1165-73. PubMed ID: 1361210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles.
    Laaksonen T; Santos H; Vihola H; Salonen J; Riikonen J; Heikkilä T; Peltonen L; Kumar N; Murzin DY; Lehto VP; Hirvonen J
    Chem Res Toxicol; 2007 Dec; 20(12):1913-8. PubMed ID: 17990852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay.
    Bruggisser R; von Daeniken K; Jundt G; Schaffner W; Tullberg-Reinert H
    Planta Med; 2002 May; 68(5):445-8. PubMed ID: 12058323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.
    Abe K; Saito H
    Neurosci Res; 1998 Aug; 31(4):295-305. PubMed ID: 9809588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.
    Berridge MV; Tan AS
    Arch Biochem Biophys; 1993 Jun; 303(2):474-82. PubMed ID: 8390225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes.
    Isobe I; Michikawa M; Yanagisawa K
    Neurosci Lett; 1999 May; 266(2):129-32. PubMed ID: 10353344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
    Kane MD; Schwarz RD; St Pierre L; Watson MD; Emmerling MR; Boxer PA; Walker GK
    J Neurochem; 1999 May; 72(5):1939-47. PubMed ID: 10217271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The further application of MTT-formazan colorimetry to studies on filarial worm viability.
    Comley JC; Townson S; Rees MJ; Dobinson A
    Trop Med Parasitol; 1989 Sep; 40(3):311-6. PubMed ID: 2617039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay.
    Jiao H; Soejima Y; Ohe Y; Miura K; Tamura T; Saijo N
    Leuk Res; 1992 Dec; 16(12):1175-80. PubMed ID: 1465025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.